<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: amd</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'amd'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22amd%22&t=%22amd%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:20:52 +0100</lastBuildDate>
        <item>
            <title>Roche, The Professor And Washington Lobbying</title>
            <link>http://www.medworm.com/index.php?rid=4768246&amp;cid=t_126584_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FwCO2OFhmr2I%2F</link>
            <description>Earlier this week, the long-awaited results of a head-to-head trial comparing two different drugs marketed by Roche&amp;#8217;s Genentech unit were leaked. The upshot? The older Avastin cancer med is about as effective as Lucentis in treating a form of age-related macular degeneration. The significance? Avastin is not approved to treat the eye afflication, but is widely used off-label and costs up to $50 injection. Lucentis is approved to treat AMD, but costs an eye-popping $2,000 for an injection.
The results, which are now available in The New England Journal of Medicine (read the abstract), placed Roche in a tight spot. The drugmaker is in the unenviable position of having to justify the cost of one of its drug that generates a significant revenue, but is not proven to be any more effective...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4768246</comments>
            <pubDate>Fri, 29 Apr 2011 14:29:25 +0100</pubDate>
            <guid isPermaLink="false">4768246</guid>        </item>
        <item>
            <title>All Eyes Are On Roche, Lucentis And Avastin</title>
            <link>http://www.medworm.com/index.php?rid=4762934&amp;cid=t_126584_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FohIUuwRLw4k%2F</link>
            <description>The results of an eagerly anticipated clinical trial are leaking out and early indications are that the Avastin cancer med is about as effective as Lucentis in treating a form of age-related macular degeneration, The New York Times writes. And while there are some caveats - full results will not be disclosed until Sunday - the message is that execs at Roche and its Genentech unit may find themselves in a quandary.
Why? Avastin is an older med approved to treat various cancers, but not the eye afflication that is common among the elderly. However, many docs have successfully used the drug on an off-label basis, especially since the price tag is low - up to $50 for injection. By comparison, Lucentis is approved to treat AMD, but costs $2,000 for an injection. And Genentech sells both drugs. ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4762934</comments>
            <pubDate>Thu, 28 Apr 2011 17:04:56 +0100</pubDate>
            <guid isPermaLink="false">4762934</guid>        </item>
        <item>
            <title>Macular Degeneration And A Healthy Lifestyle</title>
            <link>http://www.medworm.com/index.php?rid=4294634&amp;cid=t_126584_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fmacular-degeneration-and-a-healthy-lifestyle%2F2010.12.26</link>
            <description>We now have another condition that may be prevented by eating a healthy diet, exercising, and abstaining from smoking: Age-related macular degeneration (AMD).
Macular degeneration causes a loss of central vision and makes it difficult to recognize faces and read small print. The macula degenerates with age and severe macular degeneration causes blindness. Treatment is costly and doesn&amp;#8217;t work very well.
A new study published in the Archives of Ophthalmology looked at 1,313 women aged 55 to 74 years. They reviewed their diet and exercise habits. Eating a &amp;#8220;healthy diet&amp;#8221; meant 3.5 servings of fruit and vegetables, 2.3 servings of dairy, 2.7 ounces of meet and 3.5 servings of grain a day. Exercise habits and smoking history were also monitored. (more&amp;#8230;)

			
			*This ...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4294634</comments>
            <pubDate>Mon, 27 Dec 2010 01:00:00 +0100</pubDate>
            <guid isPermaLink="false">4294634</guid>        </item>
        <item>
            <title>Genentech Offers A Secret Rebate For Lucentis</title>
            <link>http://www.medworm.com/index.php?rid=4134257&amp;cid=t_126584_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F3vRiI0mzjQc%2F</link>
            <description>In an effort to promote Lucentis for treating age-related macular degeneration, Roche&amp;#8217;s Genentech is offering a confidential rebate to retinal specialists who may otherwise use Avastin, which is another med sold by the same biotech. Why bother? Avastin is not approved to treat AMD, but many docs believe it is equally effective. Then there&amp;#8217;s price - $20 to $30 an injection versus $2,000 for Lucentis.
What kind of rebates? These are offered based on volume and increased use. For volume, they range from 0.25 percent to 1.5 percent of wholesale cost, according to The New York Times. One example in a document obtained by the paper: using 600 vials a quarter yields a $8,775 rebate. Added use offers rebates from 1 percent to 1.5 percent - another 0.01 percent usage qualifies for a 1 p...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4134257</comments>
            <pubDate>Thu, 04 Nov 2010 11:35:03 +0100</pubDate>
            <guid isPermaLink="false">4134257</guid>        </item>
        <item>
            <title>For Roche, Some Tricky Safety News About Avastin</title>
            <link>http://www.medworm.com/index.php?rid=4082330&amp;cid=t_126584_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FJycNCO0uTsg%2F</link>
            <description>Nobody likes a conundrum, but that&amp;#8217;s what Roche may face now that a new paper found that both Lucentis and Avastin were no riskier for treating age-related macular degeneration, or AMD, than two other therapies, including Pfizer&amp;#8217;s Macugen. The paper, which was published in the Archives of Ophthalmology, reviewed nearly 147,000 Medicare beneficiaries who received treatment for AMD in 2005 and 2006, and who were tracked through 2007 for heart attacks, strokes and bleeding (see the abstract).
Here is the issue: Roche owns Genentech, which sells both Lucentis and Avastin, although only Lucentis is approved by the FDA to treat AMD. Nonetheless, the Avastin cancer med is used off-label by many ophthalmologists because it is much cheaper - about $1,950 versus $30 per dose. Genentech h...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4082330</comments>
            <pubDate>Tue, 19 Oct 2010 12:15:30 +0100</pubDate>
            <guid isPermaLink="false">4082330</guid>        </item>
        <item>
            <title>What Does Your Hair Color Say About Your Health?</title>
            <link>http://www.medworm.com/index.php?rid=3729848&amp;cid=t_126584_87_f&amp;fid=36050&amp;url=http%3A%2F%2Fblisstree.com%2Flive%2Fwhat-does-your-hair-color-say-about-your-health%2F</link>
            <description>photo: Thinkstock
We all love our hair. (Or we hate it.) We preen over it for way too long in the morning, we spend months deciding on a new cut or color, and definitely think our luscious locks add to our feminine wiles. But apparently, our hair can even alert us to possible health risks. Check out what your natural hair color could say about your well being, courtesy of Women&amp;#8217;s Health:
Blondes 

You&amp;#8217;re at risk for developing age-related macular degeneration (AMD), an eye condition that can lead to blindness. Eat food rich in lutein and zeaxanthin, like kale, spinach, and snow peas.
Blondes are also at the highest risk for melanoma. Make sure you wear a full-spectrum SPF 30, and wear a hat in direct sunlight. Check out some of our favorite eco-friendly hats here.

Brunettes

Y...</description>
            <author>Breastfeeding 1-2-3</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3729848</comments>
            <pubDate>Tue, 06 Jul 2010 17:49:48 +0100</pubDate>
            <guid isPermaLink="false">3729848</guid>        </item>
        <item>
            <title>Free Eye Exams for Eligible U.S. Seniors</title>
            <link>http://www.medworm.com/index.php?rid=3048198&amp;cid=t_126584_111_f&amp;fid=36048&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2Fyiee59OlFEk%2F</link>
            <description>Age-related macular degeneration (AMD) is an eye disease associated that affects the central vision &amp;#8211; in the middle of your eye. You can have wet AMD or dry AMD. People with AMD lose the sharpness in the center by affecting the macula, the part of the eye that provides you with fine details. Someone with AMD has a dark whole in the center of the vision, but can see peripherally, along the edges.
AMD affects people as they age and is listed as the leading cause of vision loss in Americans 65 years and older. There is no cure for AMD, but treatment can slow down the vision loss. Sometimes, the progress of AMD is very gradual, maybe not even noticeable at first, so it&amp;#8217;s essential that it be detected by an eye care professional. Unfortunately, eye exams are not often on the priorit...</description>
            <author>A Hearty Life</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3048198</comments>
            <pubDate>Wed, 02 Dec 2009 11:01:15 +0100</pubDate>
            <guid isPermaLink="false">3048198</guid>        </item>
        <item>
            <title>VIDEO: DASH Diet Reduces Heart Failure Risk in Women, Cognitive Function Linked to AMD</title>
            <link>http://www.medworm.com/index.php?rid=2408455&amp;cid=t_126584_87_f&amp;fid=34935&amp;url=http%3A%2F%2Fmedicine.com.my%2Fwp%2F%3Fp%3D6977</link>
            <description>, U.S. Melanoma Rates Increasing Rapidly


 strWebsiteID = window.document.location.toString();strSplitWeb = strWebsiteID.split(&quot;/&quot;)strWebsiteID = strSplitWeb[2];document.write(&amp;#8221;&amp;#8220;);


from the Malaysian Medical Resources
VIDEO: DASH Diet Reduces Heart Failure Risk in Women, Cognitive Function Linked to AMD (Source: Malaysian Medical Resources)</description>
            <author>Malaysian Medical Resources</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2408455</comments>
            <pubDate>Thu, 14 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2408455</guid>        </item>
        <item>
            <title>VIDEO: Supplements May Reduce AMD Risk Among Women, Antihypertensive Drugs Benefit Dialysis Patients, Healthy Living Habits Can Help Prevent Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2240988&amp;cid=t_126584_87_f&amp;fid=34935&amp;url=http%3A%2F%2Fmedicine.com.my%2Fwp%2F%3Fp%3D6312</link>
            <description>strWebsiteID = window.document.location.toString();strSplitWeb = strWebsiteID.split(&quot;/&quot;)strWebsiteID = strSplitWeb[2];document.write(&amp;#8221;&amp;#8220;);


from the Malaysian Medical Resources
VIDEO: Supplements May Reduce AMD Risk Among Women, Antihypertensive Drugs Benefit Dialysis Patients, Healthy Living Habits Can Help Prevent Cancer (Source: Malaysian Medical Resources)</description>
            <author>Malaysian Medical Resources</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2240988</comments>
            <pubDate>Fri, 06 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2240988</guid>        </item>
        <item>
            <title>VIDEO: Insulin May Slow Alzheimer’s Progression, Cataract Surgery Does Not Increase AMD Risk, Hormone Therapy and Breast Cancer Risk</title>
            <link>http://www.medworm.com/index.php?rid=2169826&amp;cid=t_126584_87_f&amp;fid=34935&amp;url=http%3A%2F%2Fmedicine.com.my%2Fwp%2F%3Fp%3D6128</link>
            <description>VIDEO: Insulin May Slow Alzheimer&amp;#8217;s Progression, Cataract Surgery Does Not Increase AMD Risk, Hormone Therapy and Breast Cancer Risk


 strWebsiteID = window.document.location.toString();strSplitWeb = strWebsiteID.split(&quot;/&quot;)strWebsiteID = strSplitWeb[2];document.write(&amp;#8221;&amp;#8220;);


from the Malaysian Medical Resources
VIDEO: Insulin May Slow Alzheimer&amp;#8217;s Progression, Cataract Surgery Does Not Increase AMD Risk, Hormone Therapy and Breast Cancer Risk (Source: Malaysian Medical Resources)</description>
            <author>Malaysian Medical Resources</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2169826</comments>
            <pubDate>Sun, 08 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2169826</guid>        </item>
        <item>
            <title>Five Easy Steps to Shrink Your Risk of Age Related Macular Degeneration (AMD)</title>
            <link>http://www.medworm.com/index.php?rid=1190016&amp;cid=t_126584_158_f&amp;fid=36021&amp;url=http%3A%2F%2F3genfamily.wordpress.com%2F2008%2F01%2F30%2Ffive-easy-steps-to-shrink-your-risk-of-age-related-macular-degeneration-amd%2F</link>
            <description>A Good Friend Remembered
A good friend of ours died the third week of December. We just received a note from his daughter responding to our holiday card. Unfortunately, it never reached him.
We sent cards every year even though we were never quite sure our friend could read the card. AG, now in his 60&amp;#8217;s, had worked with my husband some years ago. Macular degeneration wiped out his sight, and his ability to make a living as a computer programmer.
His vision problems were already underway when he attended our wedding 20 years ago. He soldiered on, working from home and adapting his life to his condition.
When his vision decreased to the point that he could not drive, he rode his bicycle for shopping and errands. AG amazed me with insistence on doing things for himself. He was determine...</description>
            <author>3GenFamily Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1190016</comments>
            <pubDate>Thu, 31 Jan 2008 04:29:18 +0100</pubDate>
            <guid isPermaLink="false">1190016</guid>        </item>
        <item>
            <title>Forbes and Genetic Part 3...The Genes</title>
            <link>http://www.medworm.com/index.php?rid=687107&amp;cid=t_126584_131_f&amp;fid=35743&amp;url=http%3A%2F%2Fthegenesherpa.blogspot.com%2F2007%2F06%2Fforbes-and-genetic-part-3the-genes.html</link>
            <description>So after that long and drawn out search I am most interested with the genes that these guys chose and why they chose them. I am surprised this article wouldn't have been written by a scientist or maybe a clinician. They would probably be in a better position to say how these gene polymorphisms/tests will perform.Complement Factor H LOC387715; In people with bad copies of these genes, chances of macular degeneration progressing from an early, mild form to a severe one increase 10-fold to almost 50%, according to a study in the Journal of the American Medical Association. Ok so this is true. There is another gene HTRA1 that should have been included. Together these two gene polymorphisms increase your risk of AMD by 40 fold! Also there should have been some mention of the fact that there is ...</description>
            <author>Gene Sherpas: Personalized Medicine and You</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=687107</comments>
            <pubDate>Sat, 16 Jun 2007 23:16:00 +0100</pubDate>
            <guid isPermaLink="false">687107</guid>        </item>
    </channel>
</rss>

